Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer
Conditions: Breast Cancer Interventions: Drug: Adebrelimab; Drug: dalpiciclib Sponsors: Tongji Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | HER2 | Hospitals | Research